ArticleBioinformatics (Oxford, England)2026
Structure-agnostic protein-ligand binding affinity prediction via hierarchical representation alignment.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
motivationTo enable real-world protein-ligand affinity prediction, not only out-of-distribution generalization but also robustness to variable structural availability and quality should be considered in model design.
resultsWe present AlignNet, a hierarchical representation alignment framework that mitigates intra- and inter-molecular heterogeneity to learn robust protein-ligand embeddings for generalizable affinity prediction, even from sequence-level inputs. Its intra-molecular module projects unimodal and multimodal features into a unified space, aligning augmented multimodal views for feature fusion and unimodal with multimodal embeddings to distill multimodal priors for structure-agnostic inference. Its inter-molecular module aligns protein and ligand embeddings for cross-molecular integration. Extensive experiments show that AlignNet (i) achieves highly competitive performance, with up to a 20.4% gain in SCC on the challenging LBA 30% split under sequence-only settings, suggesting improved out-of-distribution generalization; and (ii) learns well-separated affinity-related clusters, supporting reliable structure-independent prediction. AVAILABILITY AND IMPLEMENTATION: AlignNet is available at https://github.com/altriavin/AlignNet.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.